TGF-b/Smads regulate a wide variety of biological responses through transcriptional regulation of target genes. ELF, a b-spectrin, plays a key role in the transmission of TGF-b-mediated transcriptional response through Smads. ELF was originally identified as a key protein involved in endodermal stem/progenitor cells committed to foregut lineage. Also, as a major dynamic adaptor and scaffolding protein, ELF is important for the generation of functionally distinct membranes, protein sorting and the development of polarized differentiated epithelial cells. Disruption of elf results in the loss of Smad3/Smad4 activation and, therefore, a disruption of the TGF-b pathway. These observations led us to pursue the function of ELF in gastrointestinal (GI) epithelial cell-cell adhesion and tumor suppression. Here, we show a significant loss of ELF and reduced Smad4 expression in human gastric cancer tissue samples. Also, of the six human gastric cancer cell lines examined, three show deficient ELF expression. Furthermore, we demonstrate the rescue of E-cadherin-dependent homophilic cell-cell adhesion by ectopic expression of full-length elf. Our results suggest that ELF has an essential role in tumor suppression in GI cancers.
Introduction
The TGF-b pathway is critical for the execution of numerous aspects of cellular development, including cell growth, differentiation, apoptosis, adhesion and motility (Roberts and Sporn, 1990; Wall and Hogan, 1994; Moses and Serra, 1996; Derynck and Zhang, 2003; Siegel and Massague, 2003) . Inhibition or aberrant activation of these TGF-b regulated processes is implicated in many diseases, ranging from atherosclerosis and fibrotic diseases of the kidney, liver and lung to multiple cancers that include gastrointestinal (GI) tumors. The TGF-b super family comprises TGF-b's, bone morphogenetic proteins (BMPs), activins and related proteins. Signals from these proteins are conveyed through type I and II receptors, which are transmembrane serine/threonine (Ser/Thr) kinases (Kimchi et al., 1988; Chen et al., 1993; Feng and Derynck, 1997) , to specific intracellular mediators, the Smad proteins (Sporn, 1999) . Receptor-regulated Smads (R-Smads) act as direct substrates of specific type I receptors, which are phosphorylated on the last two serines at the carboxyl-terminus within a highly conserved SSXS motif (Kimchi et al., 1988; Chen et al., 1993; Wrana et al., 1994; Feng and Derynck, 1997; Siegel and Massague, 2003) . The regulation of R-Smads by the receptor kinase confers specificity in this system. Thus, Smad2 and Smad3 are substrates of TGF-b or activin receptors and mediate signaling by these ligands (Kimchi et al., 1988; Chen et al., 1993; Wrana et al., 1994; Feng and Derynck, 1997) , whereas Smad1, Smad5 and Smad8 are targets of BMP receptors and propagate BMP signals (Moses and Serra, 1996; Heldin et al., 1997; Kretzschmar et al., 1997) . Once phosphorylated, R-Smads associate with the common Smad, Smad4 (Abdollah et al., 1997; Heldin et al., 1997) , and are translocated to the nucleus where they participate in the regulation of target gene transcription such as p15, p21, E-cadherin, type I collagen and c-Myc (Attisano and Wrana, 2000) .
Adaptor proteins such as ELF, the Smad anchor for receptor activation (SARA), filamin and microtubules play a critical role in the proper control of Smad access to the receptors for activation at the cell membrane and in facilitating the complex functions of TGF-b (Tsukazaki et al., 1998; Dong et al., 2000; Tang et al., 2003) . We have demonstrated that disruption of the adaptor protein, ELF, leads to disruption of TGF-b signaling in mice, resulting in the mislocalization of Smad3, Smad4 and subsequent loss of TGF-b-dependent transcriptional response (Tang et al., 2003) . Our earlier studies have shown that ELF deficiency results in multiple developmental defects of the gut, liver, heart and neural systems, demonstrating its importance in these systems. Specifically, we noted that elf þ /À /Smad4 þ /À haploids exhibit an early severe gastric tumor phenotype with dramatic gastric hyperplasia. In addition, elf þ /À mutants develop hepatocellular carcinoma at 12 months after disruption of TGF-b signaling.
Inactivation of the TGF-b pathway is implicated in the genesis of multiple different human malignancies (Derynck and Zhang, 2003; Siegel and Massague, 2003) . As TGF-b is a potent growth inhibitor of most cell types, perturbations of TGF-b signaling result in progression of various tumors (Blobe et al., 2000) . Mutations of one of the TGF-b receptors, the TGF-b type II receptor (TbRII), have been identified in patients with hereditary nonpolyposis colon cancer (HNPCC) (Markowitz et al., 1995; Derynck and Zhang, 2003; Siegel and Massague, 2003) . Microsatellite instability resulting in inactivation of the TbRII has been demonstrated in most human colorectal cancers and gastric carcinomas (Grady et al., 1999; Woodford-Richens et al., 2001) .
Mutations have been found in both TGF-b family receptors and Smad proteins in many cancer cell lines (Eppert et al., 1996; Goggins et al., 1998; Grady et al., 1999; Takaku et al., 1999) . Moreover, mutations of TGF-b superfamily member, Smad4 (originally termed 'deleted in pancreatic carcinoma, locus 4' or DPC4), have demonstrated biallelic loss in one-half of all pancreatic cancers, one-third of colon cancers and have been associated with other malignancies as well Zhang et al., 1997; Goggins et al., 1998; Gold, 1999; Miyaki et al., 1999) . In addition, germline mutations in Smad4 cosegregate with a subgroup of patients with juvenile polyposis syndromes, an autosomal dominant disorder characterized by hamartomatous intestinal polyps and an increased risk of GI cancers (Grady et al., 1999; Takaku et al., 1999) . Occasionally, Smad4 mutations have been found in conjunction with TGF-b type I receptor (TbRI) mutations in biliary cancer (Goggins et al., 1998) and with TbRII mutations in colon cancer. However, only a fraction of sporadic GI tumors exhibit inactivating mutations in the early stages of cancer formation, suggesting that other mechanisms play a critical role in the inactivation of this pathway.
Genetic alterations are a hallmark of cancer cells. Analysis of human tumors demonstrates point mutations of the oncogenes ras, p53, bcl2, APC and DCC, among others. Mutational inactivation of the TGF-b pathway has been linked to the formation of multiple tumors, such as juvenile polyps, with progression to GI cancers (Roberts and Sporn, 1990; Rosivatz et al., 2002) . Gastric cancer remains the second most common cancer worldwide (Guilford et al., 1998; Goodman and Cockburn, 2001; Setiawan et al., 2001 ) and the 5-year survival is o20% (Guilford et al., 1998) . Most cases are detected in advanced stages, thereby assuring poor survival. However, the factors that govern progression from gastric epithelial cell hyperplasia through dysplasia to in situ carcinoma and invasive disease are poorly understood and possibly involve multiple molecules, including Ecadherin, CD44, c-erbB2, p53, tie-1, c-met, MKK4, ksam, and more recently, Smad4 (Powell et al., 1997; Guilford et al., 1998; Yokozaki, 2000; Lin et al., 2000; Ross and McKenna, 2001) . Allelic loss of chromosome 18q has been noted in intestinal-type gastric adenocarcinomas, and the inactivation of Smad4, a tumor suppressor gene located in chromosome 18q21.1, appears to play a significant role in gastric tumorigenesis (Takaku et al., 1998; Xu et al., 2000) . In previous studies, we have shown that ELF, a b-spectrin, is a crucial adaptor protein in TGF-b signaling, and is required for Smad3 and Smad4 localization and signaling (Derynck and Zhang, 2003; Tang et al., 2003) . ELF was originally identified as a key protein involved in endodermal stem/ progenitor cell commitment to foregut lineage (Mishra et al., 1998 (Mishra et al., , 1999 . Moreover, ELF, as a major dynamic scaffolding protein, is important for the generation of functionally distinct membrane protein domains, protein sorting, cell adhesion and the development of a polarized differentiated epithelial cell (Mishra et al., 1999; Tang et al., 2002) .
These findings led us to investigate the role of ELF in human GI cancers. In this present study, we show that ELF possesses potent antioncogenic activity. First, we observed a significant loss of ELF expression in human gastric tissue samples with little or reduced expression of Smad4. Next, in the six human gastric cancer cell lines examined, three showed deficient ELF expression. We found that TGF-b1 stimulation results in ELF, Smad3 and Smad4 interactions in GI cells. Furthermore, we found that disruption of ELF results in a dramatic loss of E-cadherin expression at cell-cell contacts and cellcell adhesion in the mutants. In addition, we further demonstrate rescue of E-cadherin homophilic cell-cell adhesion by ectopic expression of full-length elf. In summary, our results demonstrate that the TGF-b signaling pathway, essential for normal development and tumor suppression, is disrupted through inactivation of an adaptor protein, ELF, and therefore plays a role in the development of GI cancers.
Results

ELF and Smad4 protein expression in human gastric tissue
To determine whether ELF is linked with Smad4 expression and function in human gastric tissue, immunohistochemical analysis was performed in 57 human GI tissue biopsies and 10 gastric cancer biopsies (Tables 1 and 2 ). Similarly, Smad4 expression was strikingly absent in six out of seven (85.7%) stage IV cancers. Of the normal gastric tissues, 91.2% showed intense labeling and 8.7% showed moderate labeling for ELF (Table 2) . Also, normal epithelial cells and stromal cells were almost homogeneously stained for Smad4 (Figure 1c and d, arrows) . In all, 85% of the normal tissue showed high level of expression and 14.9% showed moderate expression for Smad4 (Table 2 ). In contrast, labeling for ELF as well as Smad4 was reduced or absent in 8/10 of advanced gastric cancer tissues (Figure 1e -h, Tables 1 and 2) , and when present, an abnormal pattern of Smad4 labeling was seen ( Figure  1g -h, Table 2 ). The expression of ELF was reduced in human gastric cancers, a pattern reminiscent of that of Smad4 expression, indicating that ELF as well as Smad4 expression may be an independent prognostic factor in advanced gastric cancer with a poor clinical outcome .
heterozygous mutants developed an exacerbated phenotype of earlier gastric hyperplasia, ectasia, foveolar gland dysplasia, hamartomas with obstructing tumors at the antrum and pylorus. Abnormal mitosis, apoptosis and glandular dilatation were seen in the polyps and hamartomas. An examination of elf þ /À mice for tumor development revealed that 40.0% elf þ /À (8/20) developed tumors of varying etiology (unpublished results).
Frequent loss of ELF expression in human gastric cancer cell lines
We examined expression of ELF, Smad2, Smad3, Smad4, TbRI and TbRII in six human gastric cancer cell lines (Figure 2 ). Among the six gastric cancer cell lines, three of these (SNU-1, NCI-N87 and HS746T; Figure 
TGF-b stimulation results in ELF, Smad3 and Smad4 interactions in GI cells
In embryonic tissues, ELF is involved in Smad4 localization. A similar interaction between ELF and Smad4 in adult tissues could result in subsequent activation of Smad4, which can act as a tumor suppressor. Our first approach in identifying the mechanism for tumorigenesis in the elf
mutants was to determine the normal expression and association of ELF with Smad4 in normal adult gastric antral cells and tissues by using immunofluorescent confocal microscopy ( Figure 3a -h). We observed that Smad4 was distributed with ELF in the cytoplasm of gastric antral cells, with weak colocalization signals ( Figure 3c ). Upon stimulation with TGF-b1, we Defects in TGF-b signaling by ELF and Smad4 V Katuri et al observed increased cytoplasm and nuclear expression of ELF, and nuclear colocalization of Smad4 and ELF in gastric antral cells (Figure 3g , arrows). Nuclei are visualized with DAPI (blue) labeling and shown as overlay with transmission picture (Figure 3d and h). ELF interactions with Smad3 and Smad4 were also apparent in normal adult gastric cell line (Figure 4a-g ). None of ELF, Smad3 or Smad4 interacted in the absence of TGF-b1 (Figure 4a ). Following stimulation with TGF-b1 for 15 min, ELF was seen to colocalize with Smad3 (Figure 4c ), suggesting that Smad3 associates with ELF. In 50% of these cells, ELF, Smad3 and Smad4 appeared to colocalize (Figure 4e ) in the cytoplasm at the 30 min time point, and by 60 min these proteins translocated into the nucleus, seen as white (Figure 4g ), suggesting that their interaction is a critical event for activation and proper intracellular localization of Smad3 and Smad4 in TGF-b signaling in normal GI tissues.
To test whether endogenous ELF binds to Smad4 in GI tissues, and to test whether this is a TGF-b-mediated event, we performed co-immunoprecipitation assays using cell extracts from normal gastric cells, unstimulated or stimulated with TGF-b1 (Figure 5a ). In the absence of TGF-b1, interaction between ELF and Smad4 was not seen (Figure 5a, lanes 1 and 5) . In general, co-precipitation of ELF with Smad4, and vice versa (Figure 5a , lanes 2 and 6), was only observed in the presence of TGF-b1, as compared to the controls (lanes 4 and 8).
Loss of ELF-Smad3-Smad4 interactions in human gastric cancer cells
We further conformed ELF, Smad3 and Smad4 interactions by co-immunoprecipitation in human gastric cancer cells upon TGF-b1 stimulation (Figure 5b , lanes 2 and 8) when compared to the positive controls (lanes 6 and 12). In the absence of TGF-b1, ELF-Smad3 and ELF-Smad4 interactions are undetectable (lanes 1 and 7). ELF-deficient human gastric cancer cells (HS746T) with or without TGF-b1 stimulation did not show any interactions either with Smad3 (lanes 3 and 4) or Smad4 (lanes 9 and 10).
In addition, we analysed ELF-Smad3-Smad4 interactions in human gastric cancer cells (Figures 5 and 6 ). Immunofluorescent confocal analysis demonstrated ELF (red), Smad3 (blue) and Smad4 (green) expression in gastric cancer cells (AGS) and they colocalize only after TGF-b1 stimulation (Figure 6f-i) .
ELF restores E-cadherin expression and E-cadherindependent cell-cell adhesion in the elf À/À mutants E-cadherin is a definitive human gastric tumor suppressor (Piepenhagen and Nelson, 1998). Therefore, to To explore the role of ELF in the maintenance of adherence junctions and cell polarity, we investigated the possibility of rescuing E-cadherin expression and normal cell-cell adhesion in the elf À/À MEFs as well as in ELF-deficient gastric cancer cell line (HS746T) through restoration of ELF activity. In normal control cells, Ecadherin is expressed at cell-cell contact sites (Figure 7b and e, arrow). In contrast, elf mutants as well as the ELF-deficient human gastric cancer cells exhibited abnormal E-cadherin expression (Figure 7c and f) . Previous studies have demonstrated that reduced expression of E-cadherin is often associated with invasive and metastasizing cancer phenotype (Behrens et al., 1992) . A full-length ELF cDNA clone was constructed, encoding the N-terminal actin and membrane binding domain, as well as the C-terminal domain that includes the ankyrin binding region, active phosphorylation sites at serine residues and a hinge region regulating oligomer formation (Mishra et al., 1998 (Mishra et al., , 1999 . We found that transient transfection of fulllength elf restored E-cadherin expression in ELF mutants (Figure 7d ), as well as in ELF-deficient human gastric cancer cell lines (HS746T) (Figure 7g ) when compare to the normal E-cadherin expression (Figure 7e) .
To define the abnormalities associated in the formation, and organization of individual cell-cell contacts in elf mutants, we used functional quantitative assays of cell-cell adhesion (Ehrlich et al., 2002) . The effects on cell populations were quantified by a hanging drop assay that measures the size of cell aggregates after being subjected to a shearing force . The rate of aggregation and strength of adhesion are reflected in this assay. When cells are forced together, the close and constant apposition of cell membranes is sufficient to allow homophilic E-cadherin binding and subsequently drive cell-cell adhesion by mass action. On average 200-400 cells were examined at each time point in each experiment. In the control, all cells in hanging drops were initially present as single cells or clusters of fewer than 10 cells (Figure 8a ). The number of cells in large clusters (>50 cells) increased by 60% at 4 h, and by >80% after 4-6 h. Resistance to trituration increased from 0% of cells remaining in clusters of >50 cells following trituration at 4 h to >90% of cells at 6 h after cell-cell adhesion. Large aggregates of cells had a weblike organization, as smaller clusters joined and cell-cell adhesion became condensed (Figures 8a). Elf À/À mutant cells developed resistance to trituration more slowly than control cells, dispersing into clusters of fewer than 10 cells at all time points upon triturating. Mutant aggregates appeared clumpy, with little appearance of cell-cell interactions (Figure 8b ). We found that correction of cell-cell contacts by transient transfection of elf À/À mutant fibroblasts with full-length elf was confirmed by rescue of substrate independent cell-cell adhesion (Figure 8c) .
Discussion
Our studies demonstrate the importance of alterations in the TGF-b signaling in gastric cancer. In this study, we have demonstrated a suppression of ELF which resulted in a reduction of Smad4 expression in a subset of human gastric cancers. In all gastric cancer cell lines tested, a disruption was observed in at least one component of the TGF-b signaling. The SNU-1 cell line was established from a poorly differentiated primary carcinoma that showed loss of ELF protein expression. Similarly, expression of ELF and Smad4 was lost in NCI-N87, a gastric carcinoma cell line that was established from a well-differentiated carcinoma of the stomach. In contrast, an HS746T cell line, established from human gastric cancer, showed only loss of ELF expression, while the rest of the TGF-b family remained active. These finding are consistent with others showing the importance of TGF-b in neoplasia and progression to cancer. The Smad4 gene, located at 18q21, has been found to undergo frequent alteration in pancreatic cancers and LOH studies have suggested that genes on chromosome 18q are frequently altered in intestinaltype gastric carcinomas (Uchino et al., 1992) . The subsequent loss of Smad4 expression seen in advanced tumors may therefore result in defective TGF-b signaling, thereby fostering tumorigenesis. Gastric tumorigenesis often occurs sporadically. However, familial clustering occurs in 12-25% of cases (Murray et al., 1996) , most characteristically in HNPCC, which is caused by genetic abnormalities of mismatch repair genes.
Earlier studies indicate that Smad4 expression is an independent prognostic factor in advanced gastric cancer with poorer clinical outcome associated with reduced Smad4 expression (Miyaki et al., 1999) . The latter studies are congruent with recent analyses of Smad4 mutations in 176 colorectal tumors, documenting loss of the second allele in 95% of invasive and metastasized carcinomas (Xiangming et al., 2001) . Thus, inactivation of Smad4 may indeed be a result of 18qLOH inactivation, leading to a more virulent cancer. The small number of cases in the present study precluded correlation of ELF expression and prognosis, as other studies have indicated with Smad4 (Miyaki et al., 1999; Xiangming et al., 2001 ). Inactivation of Smad4 leads to embryonic lethality. Heterozygous Smad4 þ /À mice develop inflammatory gastric polyps and tumors at about 12 months (Takaku et al., 1999; Xu et al., 2000) , with loss of the wild-type Smad4 allele. In the absence of oncogene mutations, progression of an inflammatory polyp to cancer via Figure 7 Interactions of ELF and E-cadherin in human gastric cancer cells. (a) ELF-deficient (HS746T) and normal cell (intact TGFb pathway members) lysates were immunoprecipitated (IP) with preimmune sera, ELF and E-cadherin antibodies and then immunoblotted (IB) with either monoclonal or polyclonal antibody to ELF and E-cadherin. In the presence of TGF-b1, coprecipitation of ELF-E-cadherin, and vice versa, is demonstrated (lanes 2 and 8) in AGS cell line when compared to the positive controls (lanes 6 and 12). ELF-E-cadherin (lanes 9 and 10) and E-cadherin-ELF (lanes 3 and 4) interactions are undetectable in ELFdeficient gastric cancer cell line either treated or untreated with TGF-b1 (HS746T). Smad4 inactivation is possible. However, because Smad4 inactivation occurs relatively late in gastric carcinogenesis, there is speculation that other parallel pathways in tumorigenesis are activated. Indeed, the functions of TGF-b signaling are more complex than simply inhibiting epithelial cell growth. TGF-b signaling can induce the growth of mesenchymal cells (Leof et al., 1986; Battegay et al., 1990) and alter the synthesis of both extracellular matrix components and metalloproteases involved in cell invasion (Laiho et al., 1986; Edwards et al., 1987; Kerr et al., 1990) . TGF-b signals can also modulate the immune response to tumors (Xu et al., 2000) , and are thought to play a role in tumor angiogenesis (Pepper and Acuna, 1997) . Here, we show that ELF binding to Smad4 is observed upon TGF-b1 stimulation, thus raising the possibility that ELF is a coadaptor protein involved in Smad4 localization and activation. a-and b-spectrins have been found in multiple vertebrate tissues such as polarized epithelial cells in the gut and kidney (Ma et al., 1993) . The role for ELF in Smad4 localization is supported in confocal micrographs (Figure 3) , demonstrating prominent colocalization at nuclear sites in gastric antral cells upon TGF-b stimulation, which suggests that these molecules interact and translocate to the cell nucleus. Interestingly, spectrins have been found to be expressed in the nuclei and bear a carboxyterminus bipartite nuclear localizing signal . Therefore, it is conceivable that ELF binds to Smad4 in the cytoplasm upon TGF-b1 activation, and assists in transporting the protein into the nucleus. Furthermore, we demonstrate that the TGF-b signaling pathway is significant in the formation of GI cancers. The cancer cells that have intact TGF-b1 signaling molecules show ELF-Smad3-Smad4 interactions upon TGF-b1 stimulation. Interestingly, ELF-deficient gastric cancer cells do not respond to TGF-b1 stimulation, suggesting that ELF plays a critical role in gastric cancer suppression. Importantly, we have shown that loss of ELF results in aberrant localization of Smad3, Smad4 and E-cadherin in gastric cancer cells. Our observation that loss of ELF expression is associated with invasive gastric carcinoma provides the first indication that induction of E-cadherin, localization by such cytoskeletal/adaptor factors, plays a role in suppression of these tumors. E-cadherin alterations have been described in some kindreds with a predisposition to poorly differentiated, diffuse gastric cancer (Guilford et al., 1998) . Familial clustering on a nongenetic basis may follow Helicobacter pylori infection, which confers a fivefold risk (Murray et al., 1996) . Previous studies have demonstrated that reduced expression of Ecadherin is often associated with invasive and metastazing cancer phenotype (Behrens et al., 1992) . Our studies indicate that ELF is involved in the targeting of proteins, such as E-cadherin, to the plasma membrane of polarized epithelial cells. Indeed, a dramatic loss of Ecadherin-induced cell-cell adhesion is seen in the elf mutant cells. Thus, while initial spatial cues are probably determined by the cadherins, b-spectrins such as ELF play a major role in recruiting E-cadherin molecules to the lateral membrane of the cell surface, and are potentially involved the development of a continuous monolayer. The histological analysis of normal gastric tissue, when compared with gastric cancer tissues, demonstrates loss of organized glandular and stromal architecture. Many studies have demonstrated the importance of adhesion proteins in normal growth, and disruption of these proteins has been associated with a malignant phenotype. This finding is characteristic of the architectural changes observed in the gastric cancer tissues. Gastric cancers are generally classified into two major histological types: localized and diffuse. The former represents a well-differentiated phenotype, whereas the latter represents a poorly differentiated phenotype (Werner et al., 2001) . Others have demonstrated that there are distinct genetic patterns associated with these histological subtypes.
Abnormalities of E-cadherin expression have also been observed in various human cancers (Dorudi et al., 1993; Gamallo et al., 1993; Oka et al., 1993) . Loss or reduction of expression of E-cadherin has been regarded as one of the main molecular events involved in the dysfunction of the cell-cell adhesion system and is associated with the more aggressive, diffuse types of gastric cancer (Oda et al., 1994; Hippo et al., 2002) . In this study, we show abnormal E-cadherin localization in the ELF-deficient cells, which is restored by ectopic expression of fulllength ELF. The disruption of E-cadherin-dependent cell-cell adhesion observed in the ELF mutant cells suggests that ELF plays an important role not only in the downstream signaling of TGF-b but also in the intracellular architecture and adhesion. Potentially, it is possible to link these two roles of ELF in the movement and orientation of proteins within the intracellular matrix.
Altogether, these studies are consistent with the established role for the spectrin skeleton in stabilizing membrane proteins and preventing their endocytosis after delivery to the membrane. It is possible that spectrins also interact within the secretory pathway to sort E-cadherin and other proteins before their arrival at the cell membrane, and it will be important to address this issue in future studies (Nelson and Hammerton, 1989; Fath et al., 1997; Nelson and Nusse, 2004) . In human gastric cancers, low levels of ELF expression are correlated with invasive carcinoma, a highly infiltrating tumor type associated with loss of E-cadherin expression. These studies indicate a strong coadaptor role for ELF, with Smad3 and Smad4, in TGF-b signaling.
Furthermore, these studies demonstrate that the absence of this interaction is associated with disruption of the signaling pathway and the development of GI cancers.
Materials and methods
Tumor cells and tissues
Gastric cancer cell lines (SNU-1, SNU-16, NCI-N87, AGS, HS746T and KATOIII) were obtained from ATCC and cultured according to the manufacturer's protocol.
The diagnosis of paraffin-mounted tissue biopsies from human gastric cancer and normal stomach was microscopically confirmed by two independent blinded pathologists and an indirect immunoperoxidase procedure was used for immunohistochemical localization of Smad4 and ELF protein, as described below.
Cancer specimens
Formalin-fixed and paraffin-embedded colorectal cancer and colon specimens were obtained from the Department of Pathology, VA Medical Center, Washington, DC, USA. In all, 10 gastric adenocarcinoma samples were collected from patients with varying grades and stages of gastric cancer, identified by the Lauren's classification, were analysed for ELF and Smad4 expression. Two independent blinded pathologists evaluated the tumors used in the study. The control samples of normal gastric tissue used in the present investigation were taken from the borders of the surgical specimens.
Statistical analysis
Global w 2 test was used to test the hypothesis that the coefficient of each variable was equal to 0. Tissue sample sets of immunohistochemical data were compared to assess the significance. A P-value r0.05 was required for statistical significance, and all tests were two-sided. All tests were performed with SPSS 10.1 software (SPSS Inc., Chicago, IL, USA).
Immunoblot and co-immunoprecipitation assay
Lysates were collected from gastric cells or wild-type MEFs and as described (Tang et al., 2003) and immunoprecipitations were performed for E-cadherin, anti-Smad2, -Smad3, -Smad4, TbRI and TbRII or anti-ELF and immunoblotted with the indicated anti-specific antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The loading control was performed under the same conditions using anti-actin or atubulin (Santa Cruz, CA, USA).
Confocal laser-scanning immunofluorescence microscopy
Colocalization studies were performed with anti-ELF, antiSmad3, anti-Smad4 or E-cadherin utilizing mouse gastric antral cells and human gastric cancer cells. Images were captured using a confocal laser scanning microscope (Bio-Rad Defects in TGF-b signaling by ELF and Smad4 V Katuri et al Laboratories) using a Â 60 oil-immersion objective lens (model Radiance 2000; Bio-Rad Laboratories), as described previously (Tang et al., 2003) . Digital images were analysed using Metamorph (Universal Imaging) and figures were prepared using Adobe Photoshop.
Histological analysis and antibody staining
Tissue samples were fixed in 4% paraformaldehyde, and embedded in paraffin by standard procedures (Tang et al., 2003) . Sections (6 mm) were stained with hematoxylin and eosin or subject to immunohistochemical analysis with antibodies. Immunohistochemical staining was performed with primary antibodies against ELF or Smad4. Sections were then incubated with peroxidase-conjugated secondary antibodies (Jackson Immuno-research Laboratories, USA) of appropriate specificity and processed for immunostain using diaminobenzidine (Sigma) and counterstaining was performed with modified Harris hematoxylin solution (Sigma).
Generation of mouse embryo-derived fibroblasts
Mouse embryo-derived fibroblasts harboring the null allele elf as well as wild type were respectively derived and cultured as described previously (Tang et al., 2003) . The fibroblasts used for the experiments were at passage 3-25. Three different elf
and wild-type fibroblast lines were tested in different experiments, and the results obtained were also independent of passage number. Representative data are shown.
Transient transfection assays
Construct expressing full-length elf or vector alone were transfected into MEF cells or human gastric cancer cells by using Effectene (Qiagen, Valencia, CA, USA) according to the manufacturer's protocols. Cells were used for confocal analysis and cell-cell adhesion assay.
Hanging drop adhesion assay
The assay was performed as described . Here, cells are forced together, and the sizes of cell aggregates and their resistance to trituration (breaking up of cell clumps) are measured. In brief, MEFs derived from the elf À/À embryos and wild-type cells were grown at low density and elf expression was induced as appropriate. Cells were trypsinized and resuspended at 2.5 Â 10 5 cells/ml in the appropriate medium containing 10% FBS. Drops (20 ml) of cell suspension were pipetted onto the inner surface of the lid of a Petri dish. The lid was then placed on the Petri dish so that the drops were hanging from the lid with the cells suspended within them. To eliminate evaporation, dishes were filled with 2 ml serum-free culture medium. At each time point, the lid was inverted and drops were separated on to a glass slide. Each drop was first triturated 10 times through a 20 ml pipette. Three random fields from each drop with and without trituration were photographed, and numbers and sizes of clusters were determined. Data are presented as the average of three independent experiments.
